{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:44:16Z","timestamp":1786167856432,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Acute acquired comitant esotropia (AACE) is an increasingly reported form of esotropia, possibly linked to the rising use of digital devices. Botulinum toxin type A (BTXA) has emerged as a minimally invasive treatment alternative to surgery, particularly for patients with diplopia. We aimed to investigate the efficacy and safety of BTXA injections in treating AACE while identifying factors contributing to successful treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>A retrospective, single-center study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study retrospectively evaluated 228 patients with AACE who received BTXA injections at a single center. Treatment outcomes, adverse events, and factors influencing success were analyzed. Successful outcomes were defined as either the absence of diplopia in the primary position or an angle of deviation of \u226410 prism diopters from orthotropia, both evaluated at more than 6 months after the last injection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The average patient age was 30.9 years, and 52% achieved successful outcomes. Transient adverse events, including blepharoptosis (24%) and hypertropia (16%), were observed. The study found that shorter duration from onset to treatment (P\u00a0=\u00a00.018) and post-treatment overcorrection (P\u00a0=\u00a00.0073) were associated with higher success rates. Although some patients required additional treatment or surgery due to recurrence, BTXA was an effective intervention for AACE, with a significant improvement in eye alignment and stereopsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early intervention with BTXA is crucial for successful outcomes and offers a safe, less invasive alternative to traditional strabismus surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10384-026-01331-6","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T05:13:22Z","timestamp":1770873202000},"page":"907-914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy, safety, and success factors of botulinum toxin type A in the treatment of acute acquired comitant esotropia"],"prefix":"10.1007","volume":"70","author":[{"given":"Makiko","family":"Ui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-8015","authenticated-orcid":false,"given":"Toshiaki","family":"Goseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinue","family":"Fueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risako","family":"Hasunuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bjo.73.8.636","volume":"73","author":"AC Clark","year":"1989","unstructured":"Clark AC, Nelson LB, Simon JW, Wagner R, Rubin SE. Acute acquired comitant esotropia. Br J Ophthalmol. 1989;73:636\u20138.","journal-title":"Br J Ophthalmol"},{"key":"1331_CR2","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1007\/s00417-023-06047-8","volume":"261","author":"Y Okita","year":"2023","unstructured":"Okita Y, Kimura A, Masuda A, Minato K, Hayashi M, Kuroda Y, et al. Yearly changes in cases of acute acquired comitant esotropia during a 12-year period. Graefes Arch Clin Exp Ophthalmol. 2023;261:2661\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"1331_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41433-024-02945-1","volume":"38","author":"JM Kim","year":"2024","unstructured":"Kim JM, Shin J, Lee YH, Lee YH. Clinical features and change in incidence of acute acquired comitant esotropia: a 15-year single-centre study in South Korea. Eye Lond. 2024;38:1529\u201334.","journal-title":"Eye Lond"},{"key":"1331_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280968","volume":"18","author":"M Roda","year":"2023","unstructured":"Roda M, di Geronimo N, Valsecchi N, Cillino G, Gambini G, Sala F, et al. Epidemiology, clinical features, and surgical outcomes of acute acquired concomitant esotropia associated with myopia. PLoS ONE. 2023;18:e0280968.","journal-title":"PLoS ONE"},{"key":"1331_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10384-023-01023-5","volume":"67","author":"H Iimori","year":"2023","unstructured":"Iimori H, Nishina S, Hieda O, Oishi K, Katagiri S, Watanabe K, et al. Clinical presentations of acquired comitant esotropia in 5\u201335 years old Japanese and digital device usage: a multicenter registry data analysis study. Jpn J Ophthalmol. 2023;67:629\u201336.","journal-title":"Jpn J Ophthalmol."},{"key":"1331_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10384-025-01171-w","volume":"69","author":"H Iimori","year":"2025","unstructured":"Iimori H, Nishikawa N, Nishina S, Yoshida T, Mori T, Hieda O, et al. Impact of prolonged digital device use on acquired comitant esotropia: ACE-DD study 2. Jpn J Ophthalmol. 2025;69:166\u201373.","journal-title":"Jpn J Ophthalmol"},{"key":"1331_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2024-001713","volume":"9","author":"N Nishikawa","year":"2024","unstructured":"Nishikawa N, Iimori H, Kinouchi R, Nishina S, Yoshida T, Hikoya A, et al. Factors affecting outcome of acquired comitant esotropia with restricted use of digital devices: ACEDD study 3. BMJ Open Ophthalmol. 2024;9:e001713.","journal-title":"BMJ Open Ophthalmol"},{"key":"1331_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0213-5","volume":"16","author":"HS Lee","year":"2016","unstructured":"Lee HS, Park SW, Heo H. Acute acquired comitant esotropia related to excessive smartphone use. BMC Ophthalmol. 2016;16:37.","journal-title":"BMC Ophthalmol"},{"key":"1331_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0161-6420(03)00102-7","volume":"110","author":"A Spierer","year":"2003","unstructured":"Spierer A. Acute concomitant esotropia of adulthood. Ophthalmology. 2003;110:1053\u20136.","journal-title":"Ophthalmology"},{"key":"1331_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2025.100134","volume":"14","author":"W Wen","year":"2025","unstructured":"Wen w, Farzavandi SK, Sato M, Quah BL, Ko ST, Surendran TS, et al. Clinical practices on acute acquired comitant esotropia: a consensus statement proposed by the Council of Asia-Pacific Strabismus and Pediatric Ophthalmology Society. Asia Pac J Ophthalmol (Phila). 2025;14:100134.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"1331_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0002-9394(58)90223-X","volume":"45","author":"HM Burian","year":"1958","unstructured":"Burian HM, Miller JE. Comitant convergent strabismus with acute onset. Am J Ophthalmol. 1958;45:55\u201364.","journal-title":"Am J Ophthalmol"},{"key":"1331_CR12","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.18240\/ijo.2022.11.16","volume":"15","author":"XQ Huang","year":"2022","unstructured":"Huang XQ, Hu XM, Zhao YJ, Ye MH, Yi BX, Zhou LH. Clinical efficacy of botulinum toxin type A on acute acquired comitant esotropia. Int J Ophthalmol. 2022;15:1845\u201351.","journal-title":"Int J Ophthalmol"},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajo.2024.02.036","volume":"263","author":"CSY Cheung","year":"2024","unstructured":"Cheung CSY, Wan MJ, Zurakowski D, Miyake N, Awadein A, Fung S, et al. A comparison of chemodnervation to incisional surgery for acute, acquired, comitant esotropia: an international study. Am J Ophthalmol. 2024;263:160\u20137.","journal-title":"Am J Ophthalmol."},{"key":"1331_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12886-022-02612-7","volume":"22","author":"L Ai","year":"2022","unstructured":"Ai L, Chen X, Guo R, Wang Y, Liu Y, Zhao J, et al. Botulinum toxin treatment for bielschowsky acquired commitant esotropia in adults. BMC Ophthalmol. 2022;22:395.","journal-title":"BMC Ophthalmol."},{"key":"1331_CR15","doi-asserted-by":"publisher","first-page":"13869","DOI":"10.1038\/s41598-019-50383-x","volume":"9","author":"LJ Lang","year":"2019","unstructured":"Lang LJ, Zhu Y, Li ZG, Zhang J, Liu Y, Chen X, et al. Comparison of botulinum toxin with surgery for the treatment of acute acquired comitant esotropia and its clinical characteristics. Sci Rep. 2019;9:13869.","journal-title":"Sci Rep."},{"key":"1331_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01739-9","volume":"20","author":"L Tong","year":"2020","unstructured":"Tong L, Yu X, Tang X, Zhang Y, Zheng S, Sun Z. Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single botulinum toxin type A injection. BMC Ophthalmol. 2020;20:464.","journal-title":"BMC Ophthalmol"},{"key":"1331_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajo.2019.09.006","volume":"209","author":"T Goseki","year":"2020","unstructured":"Goseki T, Suh SY, Robbins L, Kawai M, Kato N, Clark RA, et al. Prevalence of sagging eye syndrome in adults with binocular diplopia. Am J Ophthalmol. 2020;209:55\u201361.","journal-title":"Am J Ophthalmol."},{"key":"1331_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s10384-021-00839-3","volume":"65","author":"T Goseki","year":"2021","unstructured":"Goseki T. Sagging eye syndrome. Jpn J Ophthalmol. 2021;65:448\u201353.","journal-title":"Jpn J Ophthalmol"},{"key":"1331_CR19","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.18240\/ijo.2023.11.18","volume":"16","author":"J Cai","year":"2023","unstructured":"Cai J, Lai WX, Li X, Zhang Y, Chen J, Liu L, et al. Analysis of independent risk factors for acute acquired comitant esotropia. Int J Ophthalmol. 2023;16:1854\u20139.","journal-title":"Int J Ophthalmol."},{"key":"1331_CR20","first-page":"939","volume":"73","author":"M Ui","year":"2019","unstructured":"Ui M, Orikasa S, Okajima Y, Imai T, Inokuchi S, Sakono T, et al. Botulinum injection into the fixating eye for acquired comitant esotropia. Rinsho Ganka. 2019;73:939\u201345 ((in Japanese)).","journal-title":"Rinsho Ganka"},{"key":"1331_CR21","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/S0161-6420(86)33520-6","volume":"93","author":"CL Burns","year":"1986","unstructured":"Burns CL, Gammon JA, Gemmill MC. Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm. Ophthalmology. 1986;93:1621\u20137.","journal-title":"Ophthalmology"},{"key":"1331_CR22","first-page":"637","volume":"124","author":"O Mimura","year":"2020","unstructured":"Mimura O, Kimura A, Okamoto M, Masuda A, Gomi F. Therapeutic effect of botulinum toxin type A injection on strabismus. Nippon Ganka Gakkai Zasshi. 2020;124:637\u201343 ((in Japanese)).","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"1331_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241588","volume":"15","author":"HK Yang","year":"2020","unstructured":"Yang HK, Kim DH, Hwang JM. Botulinum toxin injection without electromyographic guidance in consecutive esotropia. PLoS ONE. 2020;15:e0241588.","journal-title":"PLoS ONE"},{"key":"1331_CR24","doi-asserted-by":"publisher","first-page":"1219419","DOI":"10.3389\/fmed.2023.1219419","volume":"10","author":"Y Li","year":"2023","unstructured":"Li Y, Tong L, Chen Y, Zhao Y, Xie B, Chen X, et al. The efficacy of botulinum toxin type A treatment and surgery for acute acquired comitant esotropia. Front Med (Lausanne). 2023;10:1219419.","journal-title":"Front Med (Lausanne)."},{"key":"1331_CR25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.4103\/ijo.IJO_2813_21","volume":"70","author":"R Neena","year":"2022","unstructured":"Neena R, Remya S, Anantharaman G. Acute acquired comitant esotropia precipitated by excessive near work during the COVID-19-induced home confinement. Indian J Ophthalmol. 2022;70:1359\u201364.","journal-title":"Indian J Ophthalmol"},{"key":"1331_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1182-2","volume":"19","author":"C Cai","year":"2019","unstructured":"Cai C, Dai H, Shen Y. Clinical characteristics and surgical outcomes of acute acquired comitant esotropia. BMC Ophthalmol. 2019;19:173.","journal-title":"BMC Ophthalmol"},{"key":"1331_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-024-03231-5","volume":"44","author":"S Guo","year":"2024","unstructured":"Guo S, Zhou Y, Xi S, Zhao C, Wen W. Advances in the diagnosis and treatment of acute acquired comitant esotropia. Int Ophthalmol. 2024;44:315.","journal-title":"Int Ophthalmol"},{"key":"1331_CR28","first-page":"CD006499","volume":"3","author":"AR Bort-Mart\u00ed","year":"2023","unstructured":"Bort-Mart\u00ed AR, Rowe FJ, Ruiz Sifre L, Sahraie A, Zaher S, Dodridge C, et al. Botulinum toxin for the treatment of strabismus. Cochrane Database Syst Rev. 2023;3:CD006499.","journal-title":"Cochrane Database Syst Rev."},{"key":"1331_CR29","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.ophtha.2021.05.009","volume":"128","author":"G Binenbaum","year":"2012","unstructured":"Binenbaum G, Chang MY, Heidary G, Repka MX, Lee MS, Hunter DG, et al. Botulinum toxin injection for the treatment of strabismus: a report by the American Academy of Ophthalmology. Ophthalmology. 2012;128:1766\u201376.","journal-title":"Ophthalmology"},{"key":"1331_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaapos.2016.04.009","volume":"20","author":"J Li","year":"2016","unstructured":"Li J, Allende A, Martin F, Fraser CL. Histopathological changes of fibrosis in human extraocular muscle caused by botulinum toxin A. J AAPOS. 2016;20:544\u20136.","journal-title":"J AAPOS"},{"key":"1331_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2024.12.025","volume":"272","author":"MTB Nguyen","year":"2025","unstructured":"Nguyen MTB, Cheung CSY, Hunter DG, Wan MJ, Gise R. Three-year outcomes of botulinum toxin versus strabismus surgery for the treatment of acute acquired comitant esotropia in children. Am J Ophthalmol. 2025;272:1\u20137.","journal-title":"Am J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01331-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01331-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:23:11Z","timestamp":1786166591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01331-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01331-6","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M. Ui, None; T. Goseki, None; A. Watanabe, None; K. Fueki, None; Y. Komiya, None; R. Hasunuma, None; N. Tsutsumi, None; H. Yoshida, None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}